NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sprouts Farmers Market, Inc. ("Sprouts" or "the Company") (NASDAQ:SFM). Investors who purchased Sprouts securities prior to June 4, 2025, and continue to hold to the present, are encouraged to […]

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI). Investors who purchased Treace Medical securities prior to May 8, 2023, and continue to hold to the present, are

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stride, Inc. ("Stride" or "the Company") (NYSE:LRN). Investors who purchased Stride securities prior to October 22, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanex Building Products Corporation ("Quanex" or "the Company") (NYSE:NX). Investors who purchased Quanex securities prior to December 12, 2024, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Insulet Corporation ("Insulet" or "the Company") (NASDAQ:PODD). Investors who purchased Insulet securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/PODD. Insulet

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Blue Owl Capital Inc. ("Blue Owl" or "the Company") (NYSE:OWL). Investors who purchased Blue Owl securities prior to February 6, 2025, and continue to hold to the present, are

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SLM Corporation a/k/a Sallie Mae ("SLM" or "the Company") (NASDAQ:SLM). Investors who purchased SLM securities prior to July 25, 2025, and continue to hold to the present, are encouraged